Department of Ophthalmology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, Kerpener Str. 62, 50924, Cologne, Germany.
F. Hoffmann-La Roche AG, Basel, Switzerland.
Graefes Arch Clin Exp Ophthalmol. 2021 Mar;259(3):623-632. doi: 10.1007/s00417-020-04910-6. Epub 2020 Sep 2.
To investigate a possible correlation between established imaging biomarkers for age-related macular degeneration and local complement system activation, measured in aqueous humor (AH) of patients with early stages of age-related macular degeneration (AMD) and controls.
This analysis included prospectively acquired AH samples of 106 eyes (35 with early/intermediate AMD, 71 controls). The levels of complement protein 3 (C3), 4 (C4), 5 (C5); activation products of complement factor 3a (C3a) and Ba, C3b/iC3b; complement factors B, D, H, I (CFB, CFD, CFH, CFI); and total protein concentration were analyzed. Quantitative levels of complement factors were correlated to the presence of reticular pseudodrusen (RPD), the presence of hyperreflective foci (HRF), and total drusen volume (DV) graded on imaging by spectral-domain optical coherence tomography and using Spearman's rank correlation test.
DV correlated with C3b/iC3b (r = 0.285; P = 0.034), C3a (r = 0.200; P = 0.047), Ba (r = 0.262; P = 0.009), and C5 (r = 430; P = 0.005), and showed a tendency towards correlation with C3a (r = 0.198; P = 0.057). HRF correlated significantly with C5 (r = 0.388; P = 0.011) and RPD showed a tendency towards correlation with CFB (r = 0.196; P = 0.050).
In patients with early AMD, HRF and drusen parameters but not RPD show low to fair levels of correlation with local complement activation in patients' AH. Better understanding of complement activation could provide some insights into the pathogenesis of AMD. Imaging biomarkers could be useful to identify suitable patients for future clinical trials with complement-modulating therapies.
研究与年龄相关性黄斑变性相关的既定影像学生物标志物与年龄相关性黄斑变性早期患者房水中局部补体系统激活之间的可能相关性(AMD)和对照组。
本分析包括前瞻性获取 106 只眼(35 只患有早期/中期 AMD,71 只对照组)的房水(AH)样本。补体蛋白 3(C3)、4(C4)、5(C5);补体因子 3a(C3a)和 Ba、C3b/iC3b 的激活产物;补体因子 B、D、H、I(CFB、CFD、CFH、CFI);以及总蛋白浓度进行分析。使用 Spearman 秩相关检验,将补体因子的定量水平与视网膜下假性神经节(RPD)的存在、高反射焦点(HRF)的存在以及通过光谱域光相干断层扫描成像分级的总硬性渗出物(DV)相关联。
DV 与 C3b/iC3b(r = 0.285;P = 0.034)、C3a(r = 0.200;P = 0.047)、Ba(r = 0.262;P = 0.009)和 C5(r = 0.430;P = 0.005)呈正相关,并且与 C3a(r = 0.198;P = 0.057)呈正相关。HRF 与 C5 呈显著相关性(r = 0.388;P = 0.011),RPD 与 CFB 呈正相关趋势(r = 0.196;P = 0.050)。
在早期 AMD 患者中,HRF 和硬性渗出物参数而非 RPD 与患者 AH 中的局部补体激活呈低度至中度相关。更好地了解补体激活可以为 AMD 的发病机制提供一些见解。成像生物标志物可用于识别适合未来补体调节治疗临床试验的患者。